Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2012 to YTD 2018 10
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
MultiVir Enters into Licensing Agreement with Moffitt Cancer Center 13
Atara Biotherapeutics and Moffitt Cancer Center Enter into Agreement 14
Certainty Therapeutics Enters into Agreement with Moffitt Cancer Center 15
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 16
Vycellix Enters into Research Agreement with Moffitt Cancer Center 17
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 18
Incyte Enters into Agreement with Moffitt Cancer Center 19
Morphogenesis Enters into Agreement with Moffitt Cancer Center 20
Ignyta Enters into Research Agreement with Moffitt Cancer Center 21
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 22
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 23
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 24
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 25
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 26
Licensing Agreements 28
Moffitt Cancer Center Enters into Licensing Agreement with Lixte Biotechnology 28
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 29
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 30
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 31
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 32
H. Lee Moffitt Cancer Center & Research Institute Inc – Key Competitors 34
H. Lee Moffitt Cancer Center & Research Institute Inc – Key Employees 35
H. Lee Moffitt Cancer Center & Research Institute Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Government and Public Interest 38
Jul 18, 2018: New studies show daily Aspirin use reduces ovarian cancer risk and improves survival after diagnosis 38
Jul 09, 2018: Moffitt Cancer Center Researcher Receives $200,000 Grant to Investigate Pancreatic Cancer 40
Jun 26, 2018: Pancreatic Cancer Action Network Funds Innovative Scientists through Research Grants Program 41
Mar 27, 2018: Screening High-Risk Individuals Can Reduce Multiple Myeloma Mortality 42
Mar 13, 2018: Moffitt researchers use single-cell imaging & math models to find effect drug properties 43
Mar 13, 2018: Moffitt Researchers Use Single-Cell Imaging and Mathematical Modeling to Determine Effective Drug Properties 44
Jun 12, 2017: Moffitt researchers identify inhibitor that overcomes drug resistance in prostate cancer 45
Jan 11, 2017: Moffitt researchers develop novel treatment to prevent graft-versus-host-disease 46
Product News 47
Oct 12, 2017: 10 SU2C Catalyst Clinical Trials Launched 47
Other Significant Developments 49
Aug 17, 2018: Moffitt Cancer Center and ITUS announce scheduling of Pre-IND Meeting with the FDA for their CAR-T therapy 49
Mar 27, 2018: Moffitt Is Only Cancer Center In Florida Named 2018 LGBTQ Healthcare Equality Leader 50
Jan 18, 2018: Lung Cancer Patients to Help Medical Community Understand the Side Effects of Immunotherapy Treatment 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Deals By Therapy Area, 2012 to YTD 2018 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2012 to YTD 2018 10
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MultiVir Enters into Licensing Agreement with Moffitt Cancer Center 13
Atara Biotherapeutics and Moffitt Cancer Center Enter into Agreement 14
Certainty Therapeutics Enters into Agreement with Moffitt Cancer Center 15
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 16
Vycellix Enters into Research Agreement with Moffitt Cancer Center 17
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 18
Incyte Enters into Agreement with Moffitt Cancer Center 19
Morphogenesis Enters into Agreement with Moffitt Cancer Center 20
Ignyta Enters into Research Agreement with Moffitt Cancer Center 21
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 22
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 23
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 24
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 25
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 26
Moffitt Cancer Center Enters into Licensing Agreement with Lixte Biotechnology 28
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 29
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 30
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 31
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 32
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Competitors 34
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Employees 35
H. Lee Moffitt Cancer Center & Research Institute Inc, Subsidiaries 37
List of Figures
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2012 to YTD 2018 10